Determining sequences and post-translational modifications of novel conotoxins in Conus victoriae using cDNA

Jennifer A Jakubowski1, David A Keays, Wayne P Kelley

  • 1Department of Chemistry and the Beckman Institute, University of Illinois, Urbana-Champaign, Illinois 61801, USA.

Insights

Researchers identified eleven novel conotoxins from Conus victoriae using molecular and mass spectrometry methods. These conotoxins, including alpha-conotoxin Vc1.1 with pain-relieving properties, exhibit unique post-translational modifications.

Area of Science:

  • Marine Biology
  • Biochemistry
  • Pharmacology

Background:

  • Conotoxins are peptides from cone snail venom with diverse pharmacological activities.
  • Conus victoriae venom is a source of novel bioactive compounds.

Purpose of the Study:

  • To identify and characterize novel conotoxins from Conus victoriae.
  • To determine the sequences and post-translational modifications of specific conotoxins.

Main Methods:

  • cDNA cloning and sequencing
  • Liquid chromatography/electrospray ionization ion trap mass spectrometry (LC/ESI-IT-MS)
  • Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
  • Nanospray ionization ion trap mass spectrometry with collisionally induced dissociation (NSI-IT-MS/CID)

Main Results:

  • Eleven novel conotoxin sequences were identified: Vc1.1 (A superfamily), Vc6.1-Vc6.6 (O superfamily), and Vc5.1-Vc5.4 (T superfamily).
  • Post-translational modifications were identified in vc1a, vc5a, and vc6a, including hydroxyproline and gamma-carboxyglutamate in vc1a.
  • Vc1.1 (alpha-conotoxin) is a 16-amino acid peptide with pain-relieving properties.

Conclusions:

  • The study expands the known diversity of conotoxins from Conus victoriae.
  • Novel conotoxins with unique post-translational modifications were characterized.
  • Vc1.1 shows potential for pain management therapies.

Related Concept Videos

Maxam-Gilbert Sequencing01:05

Maxam-Gilbert Sequencing

In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Sanger Sequencing01:57

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.